Asthma News and Research

RSS

Asthma is a common inflammatory disease affecting the airways that leads to shortness of breath, coughing and wheezing. Symptoms range from mild to severe but are generally manageable with appropriate treatment.

COVID-19: Discrimination and inequality shape risk of severe illness and death

Underlying conditions that increase risk of severe illness or death from COVID-19 are much more common among Black, Native American, and lower-income people in the United States.

28 Apr 2020

Gene defects associated with eczema, wheeze, and nasal blockage during infancy

A link has been discovered between a common gene defect and eczema, nasal blockage and wheeze among babies as young as six months, according to a new study at Brighton and Sussex Medical School.

28 Apr 2020

New guideline provides evidence-based recommendations for clinical management of EoE

Eosinophilic esophagitis (EoE) is a chronic inflammatory disease of the esophagus triggered by allergens that causes difficulty with swallowing in adults, which grows more frequent and intense over time, affecting patients' quality of life.

28 Apr 2020

New insights into asthma aerosol treatments could aid future improvements

New research has revealed new insights into common asthma aerosol treatments to aid the drug's future improvements which could benefit hundreds of millions of global sufferers.

27 Apr 2020

Four drugs that could halt preterm labor identified

As the number of preterm births in the U.S. continues to rise, there is an increasing need for new approaches to prevent preterm labor from progressing to preterm birth. Researchers have discovered a common molecular pathway in women who experience preterm labor and are using this insight to develop new treatments for woman who experience early labor.

27 Apr 2020

Women must work harder to breathe during exercise than men

While both sexes have the capacity for phenomenal athletic achievements, women on average must work harder to breathe during strenuous exercise compared to men, according to new research.

27 Apr 2020

Improvements in air quality and health during COVID-19 lockdown

COVID-19 has devastated lives and communities and will have a horrendous impact on the economy, but it has also revealed some environmental truths that we as humans may not want to hear.

24 Apr 2020

Active ingredient from parasite larvae could help treat asthma

The larvae of the roundworm Heligmosomoides polygyrus bakeri (Hpb) need a very special environment in order to survive: They have to invade the mucosal layer of the intestine in rodents, the only place where they can then develop into adult worms capable of reproduction.

24 Apr 2020

Study identifies key nose cells as likely COVID-19 virus entry points

Two specific cell types in the nose have been identified as likely initial infection points for COVID-19 coronavirus. Scientists discovered that goblet and ciliated cells in the nose have high levels of the entry proteins that the COVID-19 virus uses to get into our cells.

23 Apr 2020

The other COVID risks: How race, income, zip code influence who lives or dies

It started with a headache in late March. Then came the body aches.

22 Apr 2020

New insights into self-management plans for children with chronic conditions

With stressed hospital services, and concerns about the spread of COVID-19, experts are reminding carers of children and young people of the importance of adhering to supported chronic condition self-management plans from the safety of their home.

22 Apr 2020

Boehringer Ingelheim’s Aservo EquiHaler receives Red Dot Award for product design

Boehringer Ingelheim is proud to announce that its Aservo EquiHaler received a Red Dot Award for product design. Aservo EquiHaler is an inhalant therapy licensed for use in horses with severe equine asthma.

From Boehringer Ingelheim International GmbH 22 Apr 2020

C-Path receives FDA contract to develop clinical outcome assessments for pediatric asthma

The Critical Path Institute announced today it has been awarded a U.S. Food and Drug Administration contract in support of ongoing development of novel clinical outcome assessments for pediatric asthma.

21 Apr 2020

Report finds nearly half of the U.S. population breathing polluted air

This year marks the 50th anniversary of the Clean Air Act, which is responsible for dramatic improvements in air quality.

21 Apr 2020

COVID-19 and immunodeficiency

COVID-19 disease, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a highly infectious disease. As of today, over 170,000 people worldwide have succumbed to the infection. Reports have shown that some comorbidities and illnesses raise the risk of getting infected and also influence the severity of the disease. Having a compromised immune system can also drastically raise the risk of getting COVID-19.

21 Apr 2020